Improving Health Outcomes

The 2021 NPF Research Symposium will feature experts in psoriatic disease research.

July 29, 2021

On September 10, 2021, multi-disciplinary research leaders will come together in New York City at the National Psoriasis Foundation (NPF) Research Symposium to present on the latest in psoriasis, psoriatic arthritis (PsA), and comorbidities research and how we can accelerate these efforts to improve patient quality of life.

Psoriasis is one of the most common immune-mediated diseases affecting US adults. [1] It is associated with underlying systemic inflammatory processes that can have wide-ranging effects on a person, including the development, or manifestation, of comorbidities such as PsA, cardiovascular disease, metabolic syndrome, and mental illness.[2]

The Research Symposium, which is held every 2 years, will focus on improving health outcomes for individuals with psoriatic disease. Chaired by Iannis Adamopoulos, Ph.D., and Joseph Merola, M.D., the multi-disciplinary presentations this year will discuss health disparities, the value of using real world data, the growing body of research into the comorbidities of psoriatic disease, as well as the systemic effects of this chronic immune-mediated disease and other inflammatory diseases, among other topics.

Keynote and Plenary Sessions

Michelle McMurry-Heath, M.D., Ph.D., President and CEO of Biotechnology Innovation Organization (BIO) will provide the keynote address, where she will highlight the BIOEquality agenda as well as some of the outcomes from the recent BIO Clinical Trial Diversity Summit. Additionally, she will share how biotech is working toward breakthroughs for people with psoriasis and the types of research that are necessary to achieve those breakthroughs.

Joining Dr. McMurry-Heath on the main stage is 2021 Beverly Foster Plenary Lecture presenter, Mariana J. Kaplan, M.D., Chief of the Systemic Autoimmunity Branch at the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). Recently, her research has focused on identifying abnormalities of neutrophil subsets and the role of neutrophil extracellular traps in systemic autoimmune and immune-mediated disorders, both of which may contribute to the development of chronic inflammatory responses.

Recent Advance Articles

Many Voices, One Mission: Nehal N. Mehta

Public Health and Psoriatic Disease

Biosimilars

Investigators and Researchers on the Leading Edge

In addition to hearing from Drs. Kaplan and McMurry-Heath, symposium attendees will have access to presentations on the cutting edge of comorbidities and psoriatic disease research from investigators working throughout the country. Some highlights include:

Junko Takeshita, M.D., Ph.D., of the University of Pennsylvania, will discuss health disparities in psoriatic disease and research on ways to address them.
Seemal Desai, M.D., of Innovative Dermatology in Plano, Texas and a member of the NPF Medical Board will present about efforts to improve diagnosis and treatment of psoriasis in individuals with skin of color.
Alexis Ogdie-Beatty, M.D., of the University of Pennsylvania will present her work investigating the role of obesity in inflammation in psoriatic disease and its effect on disease activity and treatment response.
Michael Garshick, M.D., of New York University Langone Health will share his work looking into the fact that vascular stiffness is present in psoriasis and associated with biomarkers of inflammation and platelet activation to improve screening for cardiovascular risk.
Seo Young Kim, M.D., of Brigham and Women’s Hospital will present on her research using real world data studies to emulate trials to better guide treatment decisions in a real-world setting.

Space for the 2021 NPF Research Symposium is limited. The event will be hosted at the Kimpton Hotel Eventi in New York, New York on Friday, September 10, 2021, from 7:30 a.m. to 6:30 p.m. NPF will be adhering to CDC COVID-19 guidelines. Therefore, attendees will be required to wear a mask and follow appropriate social distancing guidelines. Masks and hand sanitizer will be available at the registration table. Please let us know if you have any questions or concerns.

Registration includes access to the symposium research presentations, an invitation to a networking reception on Friday evening, breakfast, lunch and coffee, and sponsor exhibits.

Early bird pricing ends on Sunday, August 1, 2021. Book your discounted guestroom, available September 8 to 11, 2021, under the 2021 NPF Symposium Research room block through the Kimpton Hotel Eventi website or by calling their central reservations office at 1-866-993-8396.

Register Now

Early bird pricing ends August 1, so register today.

References

1. Armstrong AW, Mehta MD, Schupp CW, Gondo GC, Bell SJ, Griffiths CEM. Psoriasis Prevalence in Adults in the United States. JAMA Dermatol. Published online June 30, 2021. doi:10.1001/jamadermatol.2021.2007

2. Gondo GC, Koons S, Metcalf C, Bell SJ, Mehta NN. Viewing Psoriasis as a Systemic Disease for Better Health Outcomes. JID Innov. Published online March 2, 2021. doi:10.1016/j.xjidi.2021.100007

Author

National Psoriasis Foundation

Improving Health Outcomes

Keynote and Plenary Sessions

Many Voices, One Mission: Nehal N. Mehta

Public Health and Psoriatic Disease

Biosimilars

Investigators and Researchers on the Leading Edge

Register Now

References

References

Author

Title